Y. Takeda

发表

Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life

K. Saijoh, M. Demura, Yosiki Demura, 2015, Hypertension Research.

M. Yamagishi, S. Miyamoto, M. Sakurai, 2011, Internal medicine.

Comparison of waist circumference with body mass index for predicting abdominal adipose tissue.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Diabetes research and clinical practice.

Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.

M. Yamagishi, A. Nohara, M. Kawashiri, 2012, Endocrine journal.

11β-Hydroxysteroid dehydrogenaseとステロイド受容体

Y. Takeda, R. Takeda, Ryoyu Takeda, 1992 .

Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index

K. Yoshimura, Y. Takeda, T. Yoneda, 2018, Journal of diabetes research.

Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling

M. Kawashiri, M. Demura, Y. Takeda, 2019, Hypertension Research.

Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study

M. Yamagishi, T. Takamura, S. Mori, 2018, Clinical and experimental hypertension.

Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism

M. Yamagishi, M. Demura, Y. Takeda, 2018, Oncotarget.

Severe Mitral Regurgitation As a Result of Rupture of Mitral Valve Chordae Tendineae in a Patient With Graves Disease

K. Hayashi, M. Kawashiri, T. Tsuda, 2018, Journal of the Endocrine Society.

Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension.

I. Miyamori, Y. Takeda, T. Yoneda, 1995, Hypertension.

Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.

M. Sone, H. Sasano, T. Yanase, 2014, Endocrine journal.

Medical treatment of benign insulinoma using octreotide LAR: a case report.

Y. Takeda, K. Hasatani, T. Yoneda, 2007, Endocrine journal.

Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects

Y. Takeda, T. Yoneda, R. Takeda, 2011, Hypertension Research.

Impact of New Quick Gold Nanoparticle-Based Cortisol Assay During Adrenal Vein Sampling for Primary Aldosteronism.

E. Tamiya, Y. Takamura, K. Hayashi, 2016, The Journal of clinical endocrinology and metabolism.

Risk of Colorectal Neoplasm in Patients with Acromegaly and its Relationship with Serum Growth Hormone Levels

A. Suzuki, H. Mabuchi, Y. Takeda, 2005, The American Journal of Gastroenterology.

DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases

M. Demura, Y. Takeda, T. Yoneda, 2021, International journal of molecular sciences.

Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia

M. Yasuda, M. Demura, Y. Takeda, 2019, Steroids.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.

I. Miyamori, Y. Takeda, T. Yoneda, 1996, Hypertension.

[The role of prostaglandins for norepinephrine clearance in borderline hypertension].

I. Miyamori, Y. Takeda, S. Hifumi, 1984, Nihon Naibunpi Gakkai zasshi.

Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine‐induced hypertension

A. Fujimura, I. Miyamori, H. Mabuchi, 2000, Journal of hypertension.

Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.

I. Miyamori, S. Okamoto, Y. Takeda, 1987, Endocrinologia japonica.

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study

S. Nagase, M. Demura, Y. Takeda, 2020, BMC Endocrine Disorders.

Analysis of pancreatic endocrine function in patients with IgG4-related diseases, in whom autoimmune pancreatitis was ruled out by diagnostic imaging.

M. Kawano, M. Yamagishi, J. Kobayashi, 2014, Endocrine journal.

Vascular synthesis of aldosterone: role in hypertension

Y. Takeda, 2004, Molecular and Cellular Endocrinology.

Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats

I. Miyamori, H. Mabuchi, M. Demura, 2001, Journal of hypertension.

Effects of Switching From Degludec to Glargine U300 in Patients With Type 1 Diabetes Having Large Day-to-day Glycemic Variability: a Retrospective Study

Y. Takeda, Azusa Ohbatake, T. Yoneda, 2021 .

Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients

M. Yamagishi, J. Kobayashi, A. Nohara, 2009, Clinical chemistry and laboratory medicine.

The activities of 5β-reductase and 11β-hydroxysteroid dehydrogenase in essential hypertension

I. Miyamori, Y. Takeda, T. Yoneda, 1994, Steroids.

Production of aldosterone in isolated rat blood vessels.

I. Miyamori, I. Blair, Y. Takeda, 1995, Hypertension.

Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells.

Hiroshi Yamamoto, I. Miyamori, T. Fujita, 1994 .

Angiotensin II generation in mesenteric arteries in rats: effects of nephrectomy, deoxycorticosterone and dexamethasone.

I. Miyamori, Y. Takeda, T. Matsubara, 1990, Endocrinologia japonica.

11β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN MESENTERIC ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS

P. Gathiram, I. Miyamori, Y. Takeda, 1993, Clinical and experimental pharmacology & physiology.

Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats.

I. Miyamori, Y. Takeda, T. Yoneda, 1994, Hypertension.

Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.

I. Miyamori, H. Mabuchi, M. Demura, 2000, Endocrinology.

The expression of steroidogenic enzyme genes in human vascular cells

Hiroshi Yamamoto, I. Miyamori, H. Mabuchi, 1996, Biochemistry and molecular biology international.

Vascular aldosterone in genetically hypertensive rats.

I. Miyamori, H. Mabuchi, Y. Takeda, 1997, Hypertension.

Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats.

I. Miyamori, Y. Takeda, T. Yoneda, 1991, Life sciences.

Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.

M. Yamagishi, Aoshuang Zhu, Y. Takeda, 2007, American journal of hypertension.

Participation of vascular prostacyclin for the pathogenesis of experimental glucocorticoid hypertension in rats.

I. Miyamori, S. Okamoto, Y. Takeda, 1985, Clinical and experimental hypertension. Part A, Theory and practice.

3. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells

I. Miyamori, E. Gomez-Sanchez, T. Fujita, 1994, The Journal of biological chemistry.

Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats

M. Yamagishi, Aoshuang Zhu, M. Demura, 2012, Diabetes, obesity & metabolism.

Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-β hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats

M. Yamagishi, Aoshuang Zhu, Y. Takeda, 2009, Steroids.

Dynamic CCAAT/Enhancer Binding Protein–Associated Changes of DNA Methylation in the Angiotensinogen Gene

Yuan Cheng, H. Sasano, M. Yamagishi, 2014, Hypertension.

the Angiotensinogen Gene Associated Changes of DNA Methylation in - Dynamic CCAAT/Enhancer Binding Protein

M. Yamagishi, T. Akagi, K. Saijoh, 2013 .

Angiotensin II up-regulates the expression of type A endothelin receptor in human vascular smooth muscle cells.

I. Miyamori, H. Yamamoto, Y. Takeda, 1994, Biochemistry and molecular biology international.

Cardiac Aldosterone Production in Genetically Hypertensive Rats

I. Miyamori, H. Mabuchi, M. Demura, 2000, Hypertension.

Interleukin-2 enhances the release of endothelin-1 from the rat mesenteric artery.

I. Miyamori, Y. Takeda, T. Yoneda, 1991, Life sciences.

Effect of FK 506 on the Expression of Endothelin Receptor mRNA in the Vasculature

I. Miyamori, H. Mabuchi, Y. Takeda, 1995, Journal of Cardiovascular Pharmacology.

Mechanisms of FK 506-induced hypertension in the rat.

I. Miyamori, H. Mabuchi, Y. Takeda, 1999, Hypertension.

Effects of converting enzyme inhibition on split renal function in renovascular hypertension.

T. Aburano, I. Miyamori, Y. Takeda, 1986, Hypertension.

Genetic alterations in patients with primary aldosteronism.

Y. Takeda, 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

Renal 11beta-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats.

I. Miyamori, Y. Takeda, K. Furukawa, 1998, HYPERTENSION.

19-Noraldosterone, a new mineralocorticoid.

I. Miyamori, Y. Takeda, 1994, Endocrine journal.

Formation of 18-deoxy-19- noraldosterone by a human aldosterone-producing adenoma

I. Miyamori, Y. Takeda, R. Takeda, 1993, Steroids.

Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension.

H. Mabuchi, M. Demura, Y. Takeda, 2003, The Journal of clinical endocrinology and metabolism.

Subclinical primary aldosteronism.

Y. Takeda, R. Takeda, Yuji Ito, 2012, Best practice & research. Clinical endocrinology & metabolism.

Best Practice & Research Clinical Endocrinology & Metabolism

Y. Takeda, R. Takeda, Yuji Ito, 2012 .

Primary aldosteronism, diagnosis and treatment in Japan

Y. Takeda, T. Yoneda, Shigehoro Karashima, 2011, Reviews in Endocrine and Metabolic Disorders.

Genetic analysis of the cytochrome P‐450c17α (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17α‐hydroxylase deficiency

I. Miyamori, H. Mabuchi, M. Demura, 2001, Clinical endocrinology.

Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension

Y. Takeda, 2009, Hypertension Research.

A possible new syndrome with double endocrine tumors in association with an unprecedented type of familial heart-hand syndrome: a case report

M. Kawano, M. Yamagishi, H. Mabuchi, 2010, Journal of medical case reports.

Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells.

I. Miyamori, Y. Takeda, T. Yoneda, 1993, European journal of pharmacology.

Endothelin-1 release from the mesenteric arteries of cyclosporine-treated rats.

I. Miyamori, Y. Takeda, T. Yoneda, 1992, European journal of pharmacology.

[Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients].

I. Miyamori, S. Okamoto, Y. Takeda, 1986, Nihon Naibunpi Gakkai zasshi.

Pathophysiological roles of vascular 11β-hydroxysteroid dehydrogenase and aldosterone

Y. Takeda, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

19-Noraldosterone in pregnancy-induced hypertension

H. Mabuchi, M. Demura, Y. Takeda, 2002, Steroids.

Expression of 11β-hydroxysteroid dehydrogenase mRNA in rat vascular smooth muscle cells

I. Miyamori, Y. Takeda, T. Yoneda, 1994 .

Aldosterone Overproduction and CYP11B2 mRNA Overexpression in Vessels of Spontaneously Hypertensive Rats

Y. Takeda, Zhigang Guo, W. Lai, 1998, Hormone Research in Paediatrics.

Role of prostacyclin in blood pressure regulation and aldosterone production in conscious rabbits.

I. Miyamori, Y. Takeda, T. Morise, 1984, Clinical science.

Effect of sodium intake on the excretion of urinary natriuretic factor in essential hypertensives.

I. Miyamori, S. Okamoto, Y. Takeda, 1985, Endocrinologia japonica.

Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.

I. Miyamori, H. Mabuchi, Y. Takeda, 1999, The Journal of clinical endocrinology and metabolism.

Multiple noncoding exons 1 of nuclear receptors NR4A family (NGFIB,NURR1,NOR1) and NR5A1 (SF1) in human cardiovascular and adrenal tissues

Yuan Cheng, H. Sasano, M. Yamagishi, 2011 .

Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, pravastatin, on corticosteroid metabolism in patients with heterozygous familial hypercholesterolemia.

I. Miyamori, Y. Takeda, U. Karayalcin, 1991, Hormone Research.

Aldosterone biosynthesis and action in vascular cells

Hiroshi Yamamoto, I. Miyamori, I. Blair, 1995, Steroids.

Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes.

H. Higashida, Y. Takeda, M. Hashii, 2000, The Biochemical journal.

Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes

H. Higashida, Y. Takeda, M. Hashii, 2000 .

Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia

T. Yokota, M. Yamagishi, T. Akagi, 2017, Scientific Reports.

Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.

K. Hayashi, M. Yamagishi, H. Ishibashi-Ueda, 2008, Clinical science.

Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome.

M. Yamagishi, H. Mabuchi, H. Tanii, 2008, Diabetes research and clinical practice.

Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma

S. Lewicka, Y. Takeda, P. Vecsei, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study

M. Kawashiri, D. Chujo, Y. Takeda, 2019, Diabetes Therapy.

Insulin autoimmune syndrome caused by an adhesive skin patch containing loxoprofen-sodium.

M. Yamagishi, T. Wakasugi, Y. Takeda, 2013, Internal medicine.

Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism

M. Yamagishi, S. Mori, Y. Takeda, 2016, Hypertension Research.

The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile.

M. Yamagishi, S. Mori, M. Demura, 2016, Internal medicine.

Effects of Aldosterone Blockade on Metabolic and Renal Factors in Patients with Primary Aldosteronism

M. Yamagishi, S. Mori, M. Demura, 2013 .

Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.

M. Yamagishi, Y. Takeda, T. Yoneda, 2007, American journal of hypertension.

Renin Angiotensin-Aldosterone System Aldosterone Breakthrough During Angiotensin II Receptor Blockade in Hypertensive Patients With Diabetes Mellitus

M. Yamagishi, Y. Takeda, T. Yoneda, 2007 .

Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism

H. Mabuchi, Y. Takeda, T. Yoneda, 2006, Hypertension Research.

Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II

M. Yamagishi, Makiko Meguro-Horike, M. Demura, 2018, Journal of the American Heart Association.

Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues

H. Sasano, M. Yamagishi, Yasuhiro Nakamura, 2011, Journal of hypertension.

Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy

H. Mabuchi, M. Demura, Y. Takeda, 2002, Circulation.

Stimulation of endothelin mRNA and secretion in human endothelial cells by FK 506.

I. Miyamori, Y. Takeda, T. Yoneda, 1993, Journal of cardiovascular pharmacology.

Impact of Gut Microbiome on Hypertensive Patients With Low-Salt Intake: Shika Study Results

H. Tsuboi, Akinori Hara, S. Nagase, 2020, Frontiers in Medicine.

Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer.

M. Yamagishi, S. Bulun, T. Ishizaki, 2011, Lung cancer.

Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus

H. Mabuchi, M. Demura, Y. Takeda, 2002, Human mutation.

Successful pregnancy and delivery in a patient with adult GH deficiency: role of GH replacement therapy.

M. Yamagishi, T. Wakasugi, Y. Takeda, 2011, Endocrine journal.

Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus

M. Yamagishi, S. Mori, Y. Takeda, 2016, Clinical and experimental hypertension.

Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.

Y. Takeda, 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Evidence from a study of genotyped patients.

K. Hayashi, M. Yamagishi, M. Kawashiri, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle‐aged Japanese

Yoshiyu Takeda, Kunimasa Yagi, M. Yamagishi, 2010, Obesity.

Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin.

I. Miyamori, H. Mabuchi, Y. Takeda, 1996, The Journal of clinical endocrinology and metabolism.

Endothelin-1 release from mesenteric arteries of spontaneously hypertensive rats.

I. Miyamori, Y. Takeda, T. Yoneda, 1991, Journal of cardiovascular pharmacology.

Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus

M. Yamagishi, J. Kobayashi, A. Nohara, 2013, Journal of diabetes research.

Ectopic production of parathyroid hormone in a patient with sporadic medullary thyroid cancer.

Yuan Cheng, M. Yamagishi, Y. Zen, 2010, Endocrine journal.

Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1

M. Demura, Y. Takeda, T. Yoneda, 2023, International journal of molecular sciences.

Synthesis of corticosterone in the vascular wall.

I. Miyamori, I. Blair, Y. Takeda, 1994, Endocrinology.

Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.

M. Yamagishi, M. Demura, Y. Takeda, 2012, The Journal of clinical endocrinology and metabolism.

Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

M. Yamagishi, H. Higashida, J. Kobayashi, 2009, Experimental diabetes research.

ResearchArticle Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

M. Yamagishi, H. Higashida, J. Kobayashi, 2008 .

URINARY EXCRETION OF 19‐NORALDOSTERONE IN THE SPONTANEOUSLY HYPERTENSIVE RAT AND STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RAT

I. Miyamori, Y. Takeda, T. Yoneda, 1995, Clinical and experimental pharmacology & physiology. Supplement.

Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension

I. Miyamori, Y. Takeda, R. Takeda, 1995, Steroids.

Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism

S. Lewicka, Y. Takeda, P. Vecsei, 1991, Steroids.

Effect of aging on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone

I. Miyamori, Y. Takeda, T. Yoneda, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.

I. Miyamori, H. Mabuchi, Y. Takeda, 1997, Hypertension.

Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.

I. Miyamori, H. Mabuchi, Y. Takeda, 1996, The Journal of clinical endocrinology and metabolism.

Biosynthetic pathway of 19-noraldosterone in isolated rat glomerulosa cells

I. Miyamori, Y. Takeda, T. Yoneda, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

1 Changes in Aromatase ( CYP 19 ) Gene Promoter Usage in Non-Small Cell Lung Cancer

M. Yamagishi, S. Bulun, T. Ishizaki, 2017 .

Effect of 9 alpha-fluorocortisol on the excretion of urinary digoxin-like substance in normotensive men.

I. Miyamori, S. Okamoto, S. Hifumi, 1986, Endocrinologia japonica.

Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.

I. Miyamori, Y. Takeda, T. Morise, 1985, British journal of clinical pharmacology.

The Acute Effects of Angiotensin I Converting Enzyme Inhibitor (Captopril) on Plasma Bradykinin in Renin-Independent Essential Hypertension

I. Miyamori, Y. Takeda, T. Morise, 1983 .

[The role of prostacyclin(PGI2) in the regulation of blood pressure and aldosterone response to angiotensin II].

I. Miyamori, Y. Takeda, T. Morise, 1983, Nihon Naibunpi Gakkai zasshi.

Reversible hyperkalemia induced by flufenamic acid in asymptomatic hyporeninemic patient.

I. Miyamori, Y. Takeda, T. Ito, 1985, Japanese journal of medicine.

The activities of 5 beta-reductase and 11 beta-hydroxysteroid dehydrogenase in essential hypertension.

I. Miyamori, Y. Takeda, T. Yoneda, 1994, Steroids.

Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese.

K. Hayashi, M. Yamagishi, A. Nohara, 2012, Journal of atherosclerosis and thrombosis.

Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice

M. Demura, Y. Takeda, T. Yoneda, 2020, Hypertension Research.

Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.

I. Miyamori, Y. Takeda, P. Vecsei, 1992, Acta endocrinologica.

Effect of aging on urinary excretion of 18-hydroxycortisol

I. Miyamori, Y. Takeda, T. Yoneda, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of mineralocorticoid receptor blockade on the renal renin–angiotensin system in Dahl salt-sensitive hypertensive rats

M. Yamagishi, M. Demura, Y. Takeda, 2009, Journal of hypertension.

Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes.

M. Demura, Y. Takeda, K. Yagi, 2018, Endocrine journal.

Effect of sodium intake on prostacyclin generation in rabbit mesenteric artery.

I. Miyamori, Y. Takeda, T. Morise, 1983, Japanese circulation journal.

Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism

I. Miyamori, H. Takasaki, Y. Takeda, 1992, Journal of endocrinological investigation.

Ventricular Fibrillation Associated With Dynamic Changes in J-Point Elevation in a Patient With Silent Thyroiditis

K. Hayashi, M. Kawashiri, T. Tsuda, 2017, Journal of the Endocrine Society.

Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma

M. Yamagishi, S. Mori, M. Demura, 2011, Steroids.

Surgical stress‐induced transient nephrogenic diabetes insipidus (NDI) associated with decreased Vasopressin receptor2 (AVPR2) expression linked to nonsense‐mediated mRNA decay and incomplete skewed X‐inactivation in a female patient with a heterozygous AVPR2 mutation (c. 89–90 delAC)

H. Mabuchi, Y. Bando, M. Demura, 2004, Clinical endocrinology.

The expression of messenger RNA for ADP‐ribosyl cyclase in aldosterone‐producing adenomas

Yoko Ito, H. Mabuchi, Y. Takeda, 2005, Clinical endocrinology.

A case of renovascular hypertension with incidental primary bilateral macronodular adrenocortical hyperplasia

H. Sasano, M. Demura, Y. Takeda, 2020, Endocrinology, diabetes & metabolism case reports.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

Expression Profiling of the Ephrin (EFN) and Eph Receptor (EPH) Family of Genes in Atherosclerosis-Related Human Cells

M. Yamagishi, M. Kawashiri, A. Sakamoto, 2011, The Journal of international medical research.

Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling

M. Kawashiri, M. Demura, Y. Takeda, 2019, Hypertension Research.

Decreased activity of 11 beta-hydroxysteroid dehydrogenase in mesenteric arteries of Dahl salt-sensitive rats.

I. Miyamori, Y. Takeda, T. Yoneda, 1994, Life sciences.

Idiopathic hyperaldosteronism: analysis of aldosterone synthase gene.

I. Miyamori, Y. Takeda, H. Hatakeyama, 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Role of cardiovascular aldosterone in hypertension.

Y. Takeda, 2005, Current medicinal chemistry. Cardiovascular and hematological agents.